1. Academic Validation
  2. The effect of brassinolide, a plant steroid hormone, on drug resistant small-cell lung carcinoma cells

The effect of brassinolide, a plant steroid hormone, on drug resistant small-cell lung carcinoma cells

  • Biochem Biophys Res Commun. 2017 Nov 4;493(1):783-787. doi: 10.1016/j.bbrc.2017.08.094.
David Sadava 1 Susan E Kane 2
Affiliations

Affiliations

  • 1 Department of Cancer Biology, Beckman Research Institute of the City of Hope, 1500 East Duarte Rd., Duarte, CA 91010, USA. Electronic address: [email protected].
  • 2 Department of Cancer Biology, Beckman Research Institute of the City of Hope, 1500 East Duarte Rd., Duarte, CA 91010, USA.
Abstract

Small-cell lung carcinoma (SCLC) has a dismal prognosis in part because of multidrug resistance (MDR). Epibrassinolide (EB) is a steroid hormone in Plants, with many physiological effects. It acts via a membrane receptor and GSK3 pathway, resulting in stabilization of a transcription factor. The parallels to the Wnt signaling pathway, which is activated in SCLC and results in increased β-catenin, prompted investigations of the effects of EB on drug-resistant (VPA17) and drug-sensitive (H69) SCLC cells. EB was cytotoxic to both cell lines (IC50 = 2 μM), indicating a lack of cross-resistance in the VPA17 cell line. EB was pro-apoptotic after 24 h as measured by ELISA of BUdR-labeled DNA fragments and Caspase-3 specific activity (2.5 Enzyme units/mg protein vs. 0.01 units/mg protein for untreated controls). Matrigel assays showed that EB reduced the SCLC cell invasion phenotype by 80%. Pre-incubation of VPA17 cells in 1 μM EB for 96 h reversed resistance to etoposide (IC50 = 6.0 μM, reduced to 1.8 μM with EB) and doxorubicin (IC50 = 0.37 μM, reduced to 0.09 μM). Synergism between EB and chemotherapy drugs was investigated by exposure of VPA17 cells to 1:1 ratios at the respective IC50 values, with serial dilutions at 0.25 to 2.0 × IC50 and determination of the combination index (CI). EB and etoposide showed synergism (CI = 0.80 at ED50); EB and doxorubicin also showed synergism (CI = 0.65 at ED50). Incubation of SCLC cells in EB led to a time- and dose dependent reduction of β-catenin (maximum 80% reduction). Gene expression analyses of SCLC cells showed EB incubation resulted in significant reduction in expression of β-catenin-dependent genes that are anti-apoptotic (e.g., c-Jun, Survivin), cell division-related (e.g., CCND1 cyclin, sox9), and metastasis-related (e.g., MMP7, uPAR). WIKI4, a known inhibitor of Wnt signaling, was cytotoxic to SCLC cells (IC50 = 0.02 μM). Synergism between EB and WIKI4 was determined by the CI method and showed antagonism (CI = 1.09 at ED50), suggesting that EB and WIKI4 act on the same pathway. Taken together, these data indicate that EB, a natural product with widespread occurrence in Plants, is pharmacologically active in both drug-sensitive and drug-resistant SCLC cells and acts through the Wnt signaling pathway.

Keywords

Apoptosis; Brassinolide; Lung carcinoma; Multidrug resistance; Plant hormone; Sensitization; Wnt signaling.

Figures
Products